Austrian pharmaceutical company PDC Biotech GmbH (PDC) recently announced the close of Series A financing, topping the €4 million mark. Co-leading the round were France’s Edmond de Rothschild Investment Partners and Germany’s MIG Verwaltungs AG. Combined with earlier seed funding of €1 million and a grant of €517,000, PDC’s total funding is now more than [...]